Bradyco Inc. bought a new position in Colgate-Palmolive (NYSE:CL - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 7,825 shares of the company's stock, valued at approximately $739,000.
Several other hedge funds have also added to or reduced their stakes in the stock. Kohmann Bosshard Financial Services LLC bought a new position in shares of Colgate-Palmolive during the fourth quarter valued at $26,000. Centricity Wealth Management LLC purchased a new stake in Colgate-Palmolive during the fourth quarter valued at $27,000. Union Bancaire Privee UBP SA purchased a new stake in Colgate-Palmolive during the fourth quarter valued at $32,000. Bernard Wealth Management Corp. purchased a new stake in Colgate-Palmolive during the fourth quarter valued at $36,000. Finally, Roxbury Financial LLC purchased a new stake in Colgate-Palmolive during the fourth quarter valued at $43,000. 80.41% of the stock is owned by institutional investors.
A number of analysts recently commented on the company. Piper Sandler reduced their price objective on Colgate-Palmolive from $121.00 to $112.00 and set an "overweight" rating for the company in a research report on Monday, January 6th. Wells Fargo & Company reduced their price target on Colgate-Palmolive from $92.00 to $83.00 and set an "underweight" rating for the company in a research report on Tuesday, January 7th. Stifel Nicolaus reduced their price target on Colgate-Palmolive from $95.00 to $93.00 and set a "hold" rating for the company in a research report on Monday, February 3rd. JPMorgan Chase & Co. reduced their price target on Colgate-Palmolive from $103.00 to $97.00 and set an "overweight" rating for the company in a research report on Monday, February 3rd. Finally, UBS Group reduced their price target on Colgate-Palmolive from $104.00 to $100.00 and set a "buy" rating for the company in a research report on Monday, February 3rd. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and twelve have given a buy rating to the company's stock. According to data from MarketBeat, Colgate-Palmolive has a consensus rating of "Moderate Buy" and a consensus price target of $101.61.
Get Our Latest Report on Colgate-Palmolive
NYSE CL opened at $93.30 on Friday. The company has a fifty day moving average of $88.74 and a 200 day moving average of $95.26. The company has a market capitalization of $75.72 billion, a PE ratio of 26.51, a P/E/G ratio of 4.20 and a beta of 0.44. Colgate-Palmolive has a 1 year low of $85.32 and a 1 year high of $109.30. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58.
Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter in the previous year, the firm posted $0.87 earnings per share. Research analysts forecast that Colgate-Palmolive will post 3.75 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which was paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st were issued a $0.50 dividend. The ex-dividend date of this dividend was Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.14%. Colgate-Palmolive's payout ratio is 56.82%.
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.